Table: Sapporo Clinical Lab -2020/21 parent results

Sapporo Clinical Laboratory

14/05/2021 07:30

May 14 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           16.37           16.51          16.24         8.02    
               (-0.8 pct)      (+3.2 pct)     (-0.8 pct)    (+2.1 pct) 
  Operating        1.10          912 mln                               
               (+20.4 pct)     (+20.3 pct)                             
  Recurring        1.17          944 mln        916 mln      376 mln   
               (+24.0 pct)     (+24.6 pct)    (-21.7 pct)   (-2.6 pct) 
  Net            791 mln         503 mln        550 mln      192 mln   
               (+57.2 pct)     (+3.4 pct)     (-30.4 pct)  (-20.7 pct) 
  EPS          231.10 yen      147.04 yen     160.80 yen    56.23 yen  
  Ann Div       23.00 yen       10.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       10.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T